Compare Adobe Systems Inc (ADBE) vs Eli Lilly And Co (LLY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adobe Systems Inc vs Eli Lilly And Co — how do they compare? Adobe Systems Inc trades at $219.79 (market cap $88.06B), while Eli Lilly And Co trades at $1,221.8 (market cap $1.10T). The key difference: Eli Lilly And Co is far larger — about 12.5× Adobe Systems Inc's market cap, and Eli Lilly And Co pays a 0.56% dividend while Adobe Systems Inc pays none. Which is the better fit depends on your goals.
| ADBE | LLY | |
|---|---|---|
Market Cap | $88.06B | $1.10T |
Volume | 5,187,646 | — |
Sector | Technology | Health |
52-Week High | $382.24 | $1.24K |
52-Week Low | $193.41 | $625.65 |
Enterprise Value | $89.50B | $1.14T |
Dividend Yield | — | 0.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Adobe (ADBE) trades at $221.35, up 1.5% over 24 hours, with strong fundamentals including a P/E of 12.67 and net income margin of 28.69%. Recent earnings beats and bullish analyst consensus support the stock, though technical indicators show mixed signals with RSI near overbought levels. Revenue growth remains robust, reaching $23.77B in 2025.
Outlook is positive with a consensus price target of $246.75, but risks include AI competition and recent legal scrutiny. Institutional buying activity contrasts with some selling, indicating divided sentiment. The stock presents a growth opportunity if Adobe maintains its market leadership amid industry shifts.
Eli Lilly (LLY) trades at $1,235.56, up 2.07% today, with a bullish technical signal and strong earnings momentum, having beaten EPS estimates for three consecutive quarters. Revenue surged to $65.18B in 2025, with a net income margin of 34.99%, while analyst consensus is strongly positive with a $1,310 price target. Recent news highlights expansion in China for its breast cancer drug and bullish commentary from financial media on growth prospects.
The outlook remains favorable due to robust revenue growth and high profitability, though elevated valuation ratios and regulatory risks pose challenges. Upside is supported by analyst optimism and institutional interest, but investors should monitor competitive pressures and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adobe Systems Inc
Adobe Inc. develops, markets, and supports computer software products and technologies. The Company's products allow users to express and use information across all print and electronic media. Adobe offers a line of application software products, type products, and content for creating, distributing, and managing information.
Read more on ADBE →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
